EPSILON-BIOTECH
Enterprise number 0453963661 · Active (000 Normale toestand)
EPSILON-BIOTECH is a besloten vennootschap registered in Zonhoven, Belgium, incorporated on 6 Dec 1994. Its registered activity is overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied.
Company details
- Enterprise number
- 0453963661 · official register
- Status
- 000 Normale toestand
- Legal form
- Besloten Vennootschap
- Incorporated
- 6 Dec 1994 (32 years)
- Registered address
- 3520 Zonhoven
- Province
- Limburg
- Activity
- 72190 Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
- Industry
- Scientific research and development
- Accounts overdue
- Yes
Insolvency and register events
No insolvency or liquidation events on record.
Similar companies in Limburg
- ANEUROTECH Alken
- ANIMA Clinical Alken
- ARCHEOLOGISCHE ONDERNEMING Bilzen-Hoeselt
- ARHEA Tongeren-Borgloon
- ATARANIS Tongeren-Borgloon
- Alixar Hasselt
- Amador Bioscience Hasselt
- BETA - CELL Diepenbeek
- BEX Hasselt
- BIAS, BEGELEIDING IN ARBEIDSGEBONDEN STRESS As
- BIOKEY Diepenbeek
- BIOSTRAND Diepenbeek
Questions about EPSILON-BIOTECH
What is the enterprise number of EPSILON-BIOTECH?
EPSILON-BIOTECH is registered under enterprise number 0453963661 in the official register of Belgium. View it at the official register.
Is EPSILON-BIOTECH still active?
Yes. EPSILON-BIOTECH is registered as active (status: 000 Normale toestand).
Has EPSILON-BIOTECH gone bankrupt or into insolvency?
No insolvency, bankruptcy or administration is recorded for EPSILON-BIOTECH in the official data.
When was EPSILON-BIOTECH founded?
EPSILON-BIOTECH was incorporated on 6 Dec 1994.
Where is EPSILON-BIOTECH registered?
EPSILON-BIOTECH's registered address is in 3520 Zonhoven (Limburg), Belgium.
Data: FPS Economy – KBO/BCE Open Data (KBO Open Data licence; source: FPS Economy, Crossroads Bank for Enterprises.). National Bank of Belgium – Central Balance Sheet Office web services (NBB-CBSO authentic data, free re-use under the NBB web-service terms.). Last updated 6 Nov 2026.